Treating #PTSD With MDMA-Assisted #Therapy
The investigators of MAPS' first Phase 3 trial of MDMA-assisted therapy for PTSD observed no serious safety or tolerability issues in the group that received MDMA-assisted therapy. MDMA did not increase the risk of suicidal thoughts or behaviors and did not increase cardiovascular risk or abuse potential relative to therapy with placebo. As expected from previous #ClinicalTrials, temporary increases in blood pressure and pulse were observed during MDMA sessions. Adverse events such as muscle tightness, decreased appetite, nausea, sweating, and feeling cold were transient.
The statistically significant results and excellent safety record suggest that MDMA-assisted therapy will be an effective treatment for severe, chronic PTSD.
[Part 3 of 6]
*LINK IN BIO*
#Psychedelic #Psychedelics #PsychedelicNews #PsychedelicScience #Science #PsychedelicResearch #Research #PsychedelicTherapy #PsychedelicEducation #Education #Consciousness #MassMentalHealth #MentalHealth #MDMATherapy #MDMAPTSD
